IO Biotech, Inc.
IOBT
$0.64
$0.011.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -88.35M | -103.99M | -98.46M | -95.49M | -90.34M |
| Total Depreciation and Amortization | 910.00K | 885.00K | 865.00K | 849.00K | 831.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.21M | 12.85M | 9.76M | 10.12M | 4.97M |
| Change in Net Operating Assets | 1.23M | 6.93M | 7.34M | 2.18M | -975.00K |
| Cash from Operations | -81.00M | -83.33M | -80.49M | -82.35M | -85.52M |
| Capital Expenditure | -69.00K | -75.00K | -61.00K | -44.00K | -145.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -69.00K | -75.00K | -61.00K | -44.00K | -145.00K |
| Total Debt Issued | 26.43M | 11.72M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.57M | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -251.00K | -233.00K | -- | -- | -10.00K |
| Cash from Financing | 32.76M | 11.49M | -- | -- | -10.00K |
| Foreign Exchange rate Adjustments | -1.21M | -702.00K | -349.00K | -771.00K | 356.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -49.52M | -72.62M | -80.90M | -83.16M | -85.32M |